Trials / Unknown
UnknownNCT01556802
Use of Minocicline in Patients With Stroke
Effect of Minocicline Use in Less Neurologic Sequels in Patients With Stroke
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 134 (estimated)
- Sponsor
- Hospital Universitario Hernando Moncaleano Perdomo · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will evaluate the National Institute of Health Stroke Scale/Score (NIHSS)in patients with stroke, and then give Minocycline 100mg po every 12 hours or placebo for five days, then perform periodic evaluations to determine the status and degree of neurological sequelae developed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Minocicline | Minocicline 100mg oral twice a day for 5 days |
| DRUG | Placebo | Pills with vegetable fibers one pill oral twice a day for five days |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2011-11-01
- Completion
- 2013-01-01
- First posted
- 2012-03-16
- Last updated
- 2012-03-16
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT01556802. Inclusion in this directory is not an endorsement.